S&P 500

5.322,45

0,59%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Passage Bio Inc (PASG)
Passage Bio Inc (PASG) Notícias

PASG

Passage Bio (PASG)

Passage Bio Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:PASG

1 2 3 4 5 6 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
05/06/2024	08:30	GlobeNewswire Inc.	Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference	NASDAQ:PASG	Passage Bio Inc
23/05/2024	17:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PASG	Passage Bio Inc
22/05/2024	17:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PASG	Passage Bio Inc
21/05/2024	09:00	GlobeNewswire Inc.	Passage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship Award	NASDAQ:PASG	Passage Bio Inc
14/05/2024	09:15	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PASG	Passage Bio Inc
14/05/2024	08:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PASG	Passage Bio Inc
14/05/2024	08:00	GlobeNewswire Inc.	Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights	NASDAQ:PASG	Passage Bio Inc
22/04/2024	08:00	GlobeNewswire Inc.	Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit	NASDAQ:PASG	Passage Bio Inc
05/03/2024	09:00	GlobeNewswire Inc.	Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship Program	NASDAQ:PASG	Passage Bio Inc
04/03/2024	19:22	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:PASG	Passage Bio Inc
04/03/2024	18:09	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:PASG	Passage Bio Inc
04/03/2024	09:15	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:PASG	Passage Bio Inc
04/03/2024	09:00	GlobeNewswire Inc.	Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights	NASDAQ:PASG	Passage Bio Inc
27/02/2024	09:00	GlobeNewswire Inc.	Passage Bio to Participate in Upcoming Investor Conferences	NASDAQ:PASG	Passage Bio Inc
14/02/2024	11:21	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PASG	Passage Bio Inc
20/12/2023	09:00	GlobeNewswire Inc.	Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities	NASDAQ:PASG	Passage Bio Inc
17/11/2023	18:30	GlobeNewswire Inc.	Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:PASG	Passage Bio Inc
13/11/2023	09:00	GlobeNewswire Inc.	Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights	NASDAQ:PASG	Passage Bio Inc
30/10/2023	08:00	GlobeNewswire Inc.	Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference	NASDAQ:PASG	Passage Bio Inc
20/10/2023	17:30	GlobeNewswire Inc.	Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PASG	Passage Bio Inc
25/09/2023	08:00	GlobeNewswire Inc.	Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines Conference	NASDAQ:PASG	Passage Bio Inc
07/08/2023	08:15	GlobeNewswire Inc.	Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights	NASDAQ:PASG	Passage Bio Inc
07/08/2023	08:00	GlobeNewswire Inc.	Passage Bio Announces Promising Interim Clinical Data from First Eight Patients with GM1 Gangliosidosis in Imagine-1 Study	NASDAQ:PASG	Passage Bio Inc
01/08/2023	08:00	GlobeNewswire Inc.	Passage Bio to Participate in Upcoming Investor Conferences	NASDAQ:PASG	Passage Bio Inc
31/07/2023	18:05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:PASG	Passage Bio Inc
31/07/2023	08:00	GlobeNewswire Inc.	Passage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of Directors	NASDAQ:PASG	Passage Bio Inc
29/06/2023	17:43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PASG	Passage Bio Inc
29/06/2023	17:37	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:PASG	Passage Bio Inc
05/06/2023	08:00	GlobeNewswire Inc.	Passage Bio to Present at Goldman Sachs 44th Annual Global Healthcare Conference	NASDAQ:PASG	Passage Bio Inc
26/05/2023	17:34	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PASG	Passage Bio Inc